Characterization of a model of hydrocephalus in transgenic mice

Journal of Neurosurgery

Volumn 91, Issue 6, 1999, Pages 978-988

  Cohen, Alan R ^a   Leifer, David W ^b   Zechel, Marc ^b   Flaningan, Daniel P ^b   Lewin, Jonathan S ^b   Lust, W David ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b NONE

Author keywords

Animal model; Cerebral ventricle; Cytokine; Hydrocephalus; Magnetic resonance imaging; Transforming growth factor; Transgenic mouse

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN FOURTH VENTRICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; HETEROZYGOTE; HYDROCEPHALUS; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; MENINX; MICROSCOPY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBARACHNOID SPACE; TRANSGENIC MOUSE;

EID: 0032709482     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1999.91.6.0978     Document Type: Article

References (122)

1. Abe K, Chu PJ, Ishihara A, et al: Transforming growth factor-β1 promotes re-elongation of injured axons of cultured rat hippocampal neurons. Brain Res 723:206-209, 1996
2. Assoian RK, Komoriya A, Meyers CA, et al: Transforming growth factor-β in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258:7155-7160, 1983
3. Ata AK, Funa K, Olsson Y: Expression of various TGF-β isoforms and type I receptor in necrotizing human brain lesions. Acta Neuropathol 93:326-333, 1997
4. Attisano L, Wrana JL, Lopez-Casillas F, et al: TGF-β receptors and actions. Biochim Biophys Acta 1222:71-80, 1994
5. Bachs A, Walker AE: Experimental hydrocephalus. J Neuropathol Exp Neurol 12:283-292, 1953
6. Barcellos-Hoff MH, Ehrhart EJ, Kalia M, et al: Immunohistochemical detection of active transforming growth factor-β in situ using engineered tissue. Am J Pathol 147:1228-1237, 1995
7. Becker DP, Wilson JA, Watson GW: The spinal cord central canal: response to experimental hydrocephalus and canal occlusion. J Neurosurg 36:416-424, 1972
8. Bering EA Jr, Sato O: Hydrocephalus: changes in formation and absorption of cerebrospinal fluid within the cerebral ventricles. J Neurosurg 20:1050-1063, 1963
9. Blount JP, Campbell JA, Haines SJ: Complications in ventricular cerebrospinal fluid shunting. Neurosurg Clin North Am 4:633-656, 1993
10. Bondurant CP, Jimenez DF: Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg 23:254-259, 1995
11. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
12. Border WA, Noble NA, Yamamoto T, et al: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
13. Border WA, Okuda S, Languino LR, et al: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346:371-374, 1990
14. Border WA, Ruoslahti E: Transforming growth factor-β1 in disease: the dark side of tissue repair. J Clin Invest 90:1-7, 1992
15. Borit A, Sidman RL: New mutant mouse with communicating hydrocephalus and secondary aqueductal stenosis. Acta Neuropathol 21:316-331, 1972
16. Brand T, Schneider MD: Inactive type II and type I receptors for TGFβ are dominant inhibitors of TGFβ-dependent transcription. J Biol Chem 270:8274-8284, 1995
17. Brenner M, Kisseberth WC, Su Y, et al: GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci 14:1030-1037, 1994
18. Brinster RL, Chen HY, Trumbauer ME, et al: Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci USA 82:4438-4442, 1985
19. Brunner AM, Marquardt H, Malacko AR, et al: Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor β1 precursor. Expression and characterization of mutant proteins. J Biol Chem 264:13660-13664, 1989
20. Casey A, Kimmings E, Kleinlugtebeld A, et al: The long-term outlook for hydrocephalus in childhood. Pediatr Neurosurg 27:63-70, 1997
21. Casmiro M, Benassi G, Cacciatore FM, et al: Frequency of idiopathic normal pressure hydrocephalus. Arch Neurol 46: 608, 1989 (Letter)
22. Chumas PD, Drake JM, Del Bigio MR, et al: Anaerobic glycolysis preceding white-matter destruction in experimental neonatal hydrocephalus. J Neurosurg 80:491-501, 1994
23. Constam DB, Philipp J, Malipiero UV, et al: Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblasoma cells, astrocytes, and microglia. J Immunol 148:1404-1410, 1992
24. Creange A, Belec L, Clair B, et al: Circulating transforming growth factor beta 1 (TGF-β1) in Guillain-Barre syndrome: decreased concentrations in the early course and increase with motor function. J Neurol Neurosurg Psychiatry 64:162-165, 1998
25. Dandy WE, Blackfan KD: Internal hydrocephalus. An experimental, clinical and pathological study. Am J Dis Child 8: 406-482, 1914
26. Danielpour D, Kim KY, Dart LL, et al: Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) in complex biological fluids. Growth Factors 2:61-71, 1989
27. Davidoff LM: Treatment of hydrocephalus. Historical review and description of a new method. Arch Surg 18:1737-1762, 1929
28. De S: A study of the changes in the brain in experimental internal hydrocephalus. J Pathol Bacteriol 62:197-208, 1950
29. DeFeo DR, Myers P, Foltz EL, et al: Histological examination of kaolin-induced hydrocephalus. Its implications in the therapy of animals with experimentally induced hydrocephalus. J Neurosurg 50:70-74, 1979
30. Derynck R, Feng XH: TGF-β receptor signaling. Biochim Biophys Acta 1333:F105-F150, 1997
31. Dixon WE, Heller H: Experimentelle Hypertonie durch Erhöhung des intrakraniellen Drückes. Arch Exp Pathol Pharmakol 166:265-275, 1932
32. Dohrmann GJ: Cervical spinal cord in experimental hydrocephalus. J Neurosurg 37:538-542, 1972
33. Eckstein HB, Macnab GH: Myelomeningocele and hydrocephalus. The impact of modern treatment. Lancet 1: 842-845, 1966
34. Edwards MS, Harrison MR, Halks-Miller M, et al: Kaolin-induced congenital hydrocephalus in utero in fetal lambs and rhesus monkeys. J Neurosurg 60:115-122, 1984
35. Ehrhart E, Segarini P, Tsang ML, et al: Latent transforming growth factor β1 activation in situ: quantitative and functional evidence after low-dose gamma irradiation. FASEB J 11: 991-1002, 1997
36. Eisenberg HM, McLennan JE, Welch K: Ventricular perfusion in cats with kaolin-induced hydrocephalus. J Neurosurg 41: 20-28, 1974
37. El-Sakka AI, Hassoba HM, Chui RM, et al: An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol 158:2284-2290, 1997
38. El-Sakka AI, Hassoba HM, Pillarisetty RJ, et al: Peyronie's disease is associated with an increase in transforming growth factor-β protein expression. J Urol 158:1391-1394, 1997
39. Erlebacher A, Derynck R: Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 132:195-210, 1996
40. Flanders KC, Lucecke G, Engels S, et al: Localization and actions of transforming growth factor-βs in the embryonic nervous system. Development 113:183-191, 1991
41. Flanders KC, Ren RF, Lippa CF: Transforming growth factor-βs in neurodegenerative disease. Prog Neurobiol 54:71-85, 1998
42. Flexner S: Experimental cerebro-spinal meningitis in monkeys. J Exp Med 9:142-167, 1907
43. Foltz E, Blanks J, Morton ME: Experimental transcerebral fistula. Perineural olfactory CSF flow in the normal, hydrocephalic, and postoperative hydrocephalic dog shown by radio-nuclide ventriculography. J Neurosurg 61:355-364, 1984
44. Foster L, Kozak K, Loftus M, et al: The polymerase chain reaction and its application to filamentous fungi. Mycol Res 97: 769-781, 1993
45. Galbreath E, Kim SJ, Park K, et al: Overexpression of TGF-β1 in the central nervous system of transgenic mice results in hydrocephalus. J Neuropathol Exp Neurol 54:339-349, 1995
46. Gold LI, Sung JJ, Siebert JW, et al: Type I (RI) and Type II (RII) receptors for transforming growth factor-β isoforms are expressed subsequent to transforming growth factor-β ligands during excisional wound healing. Am J Pathol 150:209-222, 1997
47. Gonzalez-Darder J, Barbera J, Cerda-Nicolas M, et al: Sequential morphological and functional changes in kaolin-induced hydrocephalus. J Neurosurg 61:918-924, 1984
48. Grande JP: Role of transforming growth factor-β in tissue injury and repair. Proc Soc Exp Biol Med 214:27-40, 1997
49. Grande JP, Melder DC, Zinsmeister AR: Modulation of collagen gene expression by cytokines: stimulatory effect of transforming growth factor-β1, with divergent effects of epidermal growth factor and tumor necrosis factor α on collagen type I and collagen type IV. J Lab Clin Med 130:476-486, 1997
50. Griffith J, Jeffers WA, Lindauer M: A study of the mechanism of hypertension following intracisternal kaolin injection in rats. Leucocytic reaction and effect on lymphatic absorption. Am J Physiol 113:285-290, 1935
51. Griffith J, Roberts E: Further studies in the mechanism of vascular hypertension following the intracisternal injection of kaolin in the rat. Am J Physiol 124:86-93, 1938
52. Haralson MA: Transforming growth factor-β, other growth factors, and the extracellular matrix. J Lab Clin Med 130: 455-458, 1997
53. Heine U, Munoz E, Flanders K, et al: Role of transforming growth factor-β1 in the development of the mouse embryo. J Cell Biol 105:2861-2876, 1987
54. Heldin CH, Miyazono K, ten Dijke P: TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471, 1997
55. Hirayama A: Histopathological study of congenital and acquired experimental hydrocephalus. Brain Dev 2:171-189, 1980
56. Hochwald GM: Animal models of hydrocephalus: recent developments. Proc Soc Exp Biol Med 178:1-11, 1985
57. Hochwald GM, Epstein F, Malhan C, et al: The relationship of compensated to decompensated hydrocephalus in the cat. J Neurosurg 39:694-697, 1973
58. Hochwald GM, Epstein F, Malhan C, et al: The role of the skull and dura in experimental feline hydrocephalus. Dev Med Child Neurol 14:65-69, 1972
59. Hochwald GM, Lux WE Jr, Sahar A, et al: Experimental hydrocephalus. Changes in cerebrospinal fluid dynamics as a function of time. Arch Neurol 26:120-129, 1972
60. Hochwald GM, Sahar A, Sadik, AR, et al: Cerebrospinal fluid production and histological observations in animals with experimental obstructive hydrocephalus. Exp Neurol 25: 190-199, 1969
61. Ichiyama T, Hayashi T, Nishikawa M, et al: Levels of transforming growth factor β1, tumor necrosis factor α, and interleukin 6 in cerebrospinal fluid: association with clinical outcome for children with bacterial meningitis. Clin Infect Dis 25:328-329, 1997
62. James AE Jr, Strecker EP: Use of silastic to produce communicating hydrocephalus. Invest Radiol 8:105-110, 1973
63. Jhappan C, Geiser AG, Kordon EC, et al: Targeting expression of a transforming growth factor β1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J 12:1835-1845, 1993
64. Johnson MD, Gold LI, Moses HL: Evidence for transforming growth factor-β expression in human leptomeningeal cells and transforming growth factor-β-like activity in human cerebrospinal fluid. Lab Invest 67:360-368, 1992
65. Johnson RT, Johnson KP: Hydrocephalus as a sequela of experimental myxovirus infections. Exp Mol Pathol 10:68-80, 1969
66. Johnson RT, Johnson KP: Hydrocephalus following viral infection: the pathology of aqueductal stenosis developing after experimental mumps virus infection. J Neuropathol Exp Neurol 27:591-606, 1968
67. Johnson RT, Johnson KP, Edmonds CJ: Virus-induced hydrocephalus: development of aqueductal stenosis in hamsters after mumps infection. Science 157:1066-1067, 1967
68. Jones HC, Bucknall RM: Inherited prenatal hydrocephalus in the H-Tx rat: a morphological study. Neuropathol Appl Neurobiol 14:263-274, 1988
69. Jones HC, Harris NG, Briggs RW, et al: Shunt treatment at two postnatal ages in hydrocephalic H-Tx rats quantified using MR imaging. Exp Neurol 133:144-152, 1995
70. Jones HC, Harris NG, Inglis BA, et al: Reduced cortical metabolites are avoided by early shunt-treatment in congenitally hydrocephalic rats. J Cereb Blood Flow Metab 15 (Suppl 1): S585, 1995 (Abstract)
71. Jones HC, Richards HK, Bucknall RM, et al: Local cerebral blood flow in rats with congenital hydrocephalus. J Cereb Blood Flow Metab 13:531-534, 1993
72. Kitazawa K, Tada T: Elevation of transforming growth factor β-1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage. Stroke 25: 1400-1404, 1994
73. Kopp JB, Factor VM, Mozes M, et al: Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 74:991-1003, 1996
74. Kriegelstein K, Rufer M, Suter-Crazzolara C, et al: Neural functions of the transforming growth factor β. Int J Dev Neurosci 13:301-315, 1995
75. Krupinski J, Kumar P, Kumar S, et al: Increased expression of TGF-β1 in brain tissue after ischemic stroke in humas. Stroke 27:852-857, 1996
76. Kulkarni AB, Huh CG, Becker D, et al: Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90: 770-774, 1993
77. Kumar AJ, Hochwald GM, Kricheff I, et al: Positive contrast ventriculography in cats with experimental obstructive hydrocephalus. Invest Radiol 11:605-611, 1976
78. Kuruvilla A, Shah R, Hochwald GM, et al: Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 88:2918-2921, 1991
79. Laurence KM, Coates S: The natural history of hydrocephalus. Detailed analysis of 182 unoperated cases. Arch Dis Child 37: 345-362, 1962
80. Lee MS, Gu D, Feng L, et al: Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor beta 1. Am J Pathol 147:42-52, 1995
81. Letterio JJ, Geiser AG, Kulkarni AB, et al: Maternal rescue of transforming growth factor-β1 null mice. Science 264: 1936-1938, 1994
82. Logan A, Berry M: Transforming growth factor-β1 and basic fibroblast growth factor in the injured CNS. Trends Pharmacol Sci 14:337-342, 1993
83. Logan A, Berry M, Gonzalez AM, et al: Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat. Eur J Neurosci 6:355-363, 1994
84. Lovely TJ, McAllister JP II, Miller DW, et al: Effects of hydrocephalus and surgical decompression on cortical norepinephrine levels in neonatal rats. Neurosurgery 24:43-52, 1989
85. Margolis G, Kilham L: Induction of congenital hydrocephalus in hamsters with parainfluenza type 2 virus. Exp Mol Pathol 27:235-248, 1977
86. Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641, 1990
87. Masters C, Alpers M, Kakulas B: Pathogenesis of reovirus type 1 hydrocephalus in mice. Significance of aqueductal changes. Arch Neurol 34:18-28, 1977
88. McAllister JP II, Cohen MI, O'Mara KA, et al: Progression of experimental infantile hydrocephalus and effects of ventriculoperitoneal shunts: an analysis correlating magnetic resonance imaging with gross morphology. Neurosurgery 29: 329-340, 1991
89. Milhorat TH: Experimental hydrocephalus. 1: A technique for producing obstructive hydrocephalus in the monkey. J Neurosurg 32:385-389, 1970
90. Milhorat TH: Hydrocephalus: pathophysiology and clinical features, in Wilkins RH, Rengachary SS (eds): Neurosurgery. New York: McGraw-Hill, 1996, Vol 3, pp 3625-3631
91. Nigam R, Singhal SL: Hydrocephalus - experimental observations. Indian J Surg 21:12-20, 1959
92. Nulsen FE, Spitz EB: Treatment of hydrocephalus by direct shunt from ventricle to jugular vein. Surg Forum 2:399-403, 1952
93. Peacock W: Prevention and management of cerebrospinal fluid shunt complications. Prog Neurol Surg 13:114-130, 1990
94. Pople IK, Quinn MW, Bayston R: Morbidity and outcome of shunted hydrocephalus. Z Kinderchir 45 (Suppl 1):29-31, 1990
95. Pudenz RH, Foltz EL: Hydrocephalus: overdrainage by ventricular shunts. A review and recommendations. Surg Neurol 35:200-212, 1991
96. Raghow R: The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 8:823-831, 1994
97. Raimondi AJ, Clark SJ, McLone DG: Pathogenesis of aqueductal occlusion in congenital murine hydrocephalus. J Neurosurg 45:66-77, 1976
98. Roberts AB, Anzano MA, Lamb LC, et al: New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 78:5339-5343, 1981
99. Rollnick JD, Sindern E, Schweppe C, et al: Biologically active TGF-β1 is increased in cerebrospinal fluid while it is reduced in serum in multiple sclerosis patients. Acta Neurol Scand 96: 101-105, 1997
100. Roth P, Cohen AR: Management of hydrocephalus in infants and children, in Tindall GT, Cooper PR, Barrow DL (eds): The Practice of Neurosurgery. Baltimore: Williams & Wilkins, 1996, pp 2707-2728
101. Rubin RC, Hochwald GM, Tiell M, et al: Hydrocephalus I: histological and ultrastructural changes in the pre-shunted cortical mantle. Surg Neurol 5:109-114, 1976
102. Rubin RC, Hochwald GM, Tiell M, et al: Hydrocephalus II: cell number and size, and myelin content of the pre-shunted cerebral cortical mantle. Surg Neurol 5:115-118, 1976
103. Sanderson N, Factor V, Nagy P, et al: Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92: 2572-2576, 1995
104. Schurr PH, McLaurin RL, Ingraham FD: Experimental studies on the circulation of the cerebrospinal fluid and methods of producing communicating hydrocephalus in the dog. J Neurosurg 10:515-525, 1953
105. Sellheyer K, Bickenbach JR, Rothnagel JA, et al: Inhibition of skin development by overexpression of transforming growth factor β1 in the epidermis of transgenic mice. Proc Natl Acad Sci USA 90:5237-5241, 1993
106. Shah M, Foreman DM, Ferguson MW: Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 108:985-1002, 1995
107. Shull MM, Ormsby I, Kier AB, et al: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693-699, 1992
108. Tada T, Kanaji M, Kobayashi S: Induction of communicating hydrocephalus in mice by intrathecal injection of human recombinant transforming growth factor-β1. J Immunol 50: 153-158, 1994
109. Van der Waal EA, Gomez-Pinilla F, Cotman CW: Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies. Neuroreport 4:69-72, 1993
110. Vawter MP, Dillon-Carter O, Issa F, et al: Transforming growth factors β1 and β2 in the cerebrospinal fluid of chronic schizophrenic patients. Neuropsychopharmacology 16: 83-87, 1997
111. Vawter MP, Dillon-Carter O, Tourtellotte WW, et al: TGFβ1 and TGFβ2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. Exp Neurol 142:313-322, 1996
112. Wahl SM, Allen JB, McCartney-Francis N, et al: Macrophage-and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immunodeficiency syndrome. J Exp Med 173:981-991, 1991
113. Weller RO, Wisniewski H: Histological and ultrastructural changes with experimental hydrocephalus in adult rats. Brain 92:819-828, 1969
114. Wislocki GB, Putnam TJ: Absorption from the ventricles in experimentally produced internal hydrocephalus. Am J Anat 29:313-320, 1921
115. Wolfson BJ, McAllister JP II, Lovely TJ, et al: Sonographic evaluation of experimental hydrocephalus in kittens. AJNR 10:1065-1067, 1989
116. Wrana JL, Attisano L, Wieser R, et al: Mechanism of activation of the TGF-β receptor. Nature 370:341-347, 1994
117. Wyss-Coray T, Feng L, Masliah E, et al: Increase central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1. Am J Pathol 147: 53-67, 1995
118. Yamaguchi Y, Mann DM, Ruoslahti E: Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346:281-284, 1990
119. Yashon D, Jane JA, Sugar O: The course of severe untreated infantile hydrocephalus. Prognostic significance of the cerebral mantle. J Neurosurg 23:509-516, 1965
120. Yoon CH, Slaney J: Hydrocephalus: a new mutation in the Syrian golden hamster. J Hered 63:344-346, 1972
121. Yoshimoto T, Houkin K, Takahashi A, et al: Evaluation of cytokines in cerebrospinal fluid from patients with Moyamoya disease. Clin Neurol Neurosurg 99 (Suppl 2):S218-S220, 1997
122. Zhang K, Flanders KC, Phan SH: Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis. Am J Pathol 147:352-361, 1995